Amanta Healthcare, an Ahmedabad-based pharmaceutical company, made a robust debut on the Indian stock exchanges, with its shares listing at a premium over the initial public offering (IPO) price.

Listing Details

The company's shares opened at ₹135 on the National Stock Exchange (NSE) and ₹134 on the Bombay Stock Exchange (BSE). These opening prices represent premiums of 7.14% and 6.35% respectively, compared to the IPO price of ₹126 per share. The strong listing aligns with grey market expectations, which had indicated a ₹9 premium.

IPO Performance

Amanta Healthcare's IPO garnered significant interest from investors, with the issue being oversubscribed 82.61 times overall. Non-Institutional Investors showed particularly strong enthusiasm, with their portion being subscribed 209.42 times.

Capital Raised and Utilization

The company successfully raised ₹126.00 crore through a fresh equity issue in its IPO. Additionally, it secured ₹37.80 crore from anchor investors. Amanta Healthcare plans to utilize the proceeds for expanding its manufacturing capabilities and for general corporate purposes.

Financial Performance

Amanta Healthcare has demonstrated improved profitability in recent years:

While the company experienced a slight decrease in revenue from ₹280.30 crore to ₹274.70 crore, it significantly improved its profit after tax from ₹3.60 crore to ₹10.50 crore during the same period.

The strong market debut and investor interest in Amanta Healthcare's IPO reflect positive sentiment towards the pharmaceutical sector and the company's growth prospects.

Amanta Healthcare, a sterile liquid pharmaceuticals manufacturer, is set to finalize its Initial Public Offering (IPO) allotment today following an impressive 82.60 times oversubscription. The Rs 126.00 crore IPO, which ran from September 1-3, garnered strong interest across investor categories.

Subscription Details

The IPO witnessed robust demand across all investor segments:

IPO Structure and Pricing

• Total offer size: Rs 126.00 crore
• Fresh shares issued: One crore
• Issue price: Rs 126.00 per share
• Anchor investor portion: Rs 38.00 crore (raised prior to public opening)

Grey Market Premium

The Grey Market Premium for Amanta Healthcare stands at Rs 9.00-10.00, representing a 7% premium over the issue price of Rs 126.00.

Key Dates

• Share credit to demat accounts: September 5
• Listing on BSE and NSE: September 8

Fund Utilization

The primary use of the IPO proceeds includes:

• Rs 100.00 crore allocated for capital expenditure to fund new sterile product manufacturing lines at Hariyala, Gujarat

Company Overview

Amanta Healthcare, incorporated in 1994, specializes in developing and manufacturing:

• IV fluids
• Diluents
• Ophthalmic solutions
• Respiratory care products
• Irrigation solutions

The company has a strong export presence, serving 21 countries across Africa, Latin America, and the UK.

Conclusion

The overwhelming response to Amanta Healthcare's IPO, particularly from non-institutional investors, reflects strong market confidence in the company's prospects. As the allotment finalizes today, investors will be keenly watching the stock's performance when it lists on the BSE and NSE on September 8.